A retrospective, multicenter study to assess the characteristics and outcomes of Polycythaemia-vera patients who discontinue ruxolitinib
Latest Information Update: 17 Dec 2021
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Polycythaemia vera
- Focus Adverse reactions
- 17 Dec 2021 New trial record